These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23690668)

  • 41. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
    Bonavita E; Gentile S; Rubino M; Maina V; Papait R; Kunderfranco P; Greco C; Feruglio F; Molgora M; Laface I; Tartari S; Doni A; Pasqualini F; Barbati E; Basso G; Galdiero MR; Nebuloni M; Roncalli M; Colombo P; Laghi L; Lambris JD; Jaillon S; Garlanda C; Mantovani A
    Cell; 2015 Feb; 160(4):700-714. PubMed ID: 25679762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair.
    Grčević D; Sironi M; Valentino S; Deban L; Cvija H; Inforzato A; Kovačić N; Katavić V; Kelava T; Kalajzić I; Mantovani A; Bottazzi B
    Front Immunol; 2018; 9():417. PubMed ID: 29556234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PENTRAXIN 3 AS A NEW CARDIOVASCULAR MARKER IN ADRENAL ADENOMAS.
    Kizilgul M; Beysel S; Ozcelik O; Kan S; Apaydin M; Caliskan M; Ucan B; Sencar E; Ozdemir S; Cakal E
    Endocr Pract; 2017 Jun; 23(6):662-668. PubMed ID: 28332877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of valsartan and nebivolol treatment on ADMA and pentraxin-3 levels in hypertensive patients.
    Parlak A; Iyisoy A; Aydogan U; Cakir E; Saglam K
    Med Hypotheses; 2012 Sep; 79(3):294-8. PubMed ID: 22698960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of long pentraxin 3 in human nasal mucosa fibroblasts, tissues, and secretions of chronic rhinosinusitis without nasal polyps.
    Tsai YJ; Hao CY; Chen CL; Wu PH; Wu WB
    J Mol Med (Berl); 2020 May; 98(5):673-689. PubMed ID: 32239253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation.
    Deban L; Jarva H; Lehtinen MJ; Bottazzi B; Bastone A; Doni A; Jokiranta TS; Mantovani A; Meri S
    J Immunol; 2008 Dec; 181(12):8433-40. PubMed ID: 19050261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pentraxin 3 in Cardiovascular Disease.
    Ristagno G; Fumagalli F; Bottazzi B; Mantovani A; Olivari D; Novelli D; Latini R
    Front Immunol; 2019; 10():823. PubMed ID: 31057548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.
    Witasp A; Carrero JJ; Michaëlsson K; Ahlström H; Kullberg J; Adamsson V; Risérus U; Larsson A; Helmersson-Karlqvist J; Lind L; Stenvinkel P; Arnlöv J
    Obesity (Silver Spring); 2014 May; 22(5):1373-9. PubMed ID: 24415446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition.
    Ma YJ; Doni A; Hummelshøj T; Honoré C; Bastone A; Mantovani A; Thielens NM; Garred P
    J Biol Chem; 2009 Oct; 284(41):28263-28275. PubMed ID: 19632990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentraxins in humoral innate immunity.
    Inforzato A; Bottazzi B; Garlanda C; Valentino S; Mantovani A
    Adv Exp Med Biol; 2012; 946():1-20. PubMed ID: 21948359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pentraxins in the activation and regulation of innate immunity.
    Daigo K; Inforzato A; Barajon I; Garlanda C; Bottazzi B; Meri S; Mantovani A
    Immunol Rev; 2016 Nov; 274(1):202-217. PubMed ID: 27782337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors.
    Alberti L; Gilardini L; Zulian A; Micheletto G; Peri G; Doni A; Mantovani A; Invitti C
    Atherosclerosis; 2009 Feb; 202(2):455-60. PubMed ID: 18571180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pentraxins, humoral innate immunity and tissue injury.
    Manfredi AA; Rovere-Querini P; Bottazzi B; Garlanda C; Mantovani A
    Curr Opin Immunol; 2008 Oct; 20(5):538-44. PubMed ID: 18579363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
    Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.
    Hudzik B; Danikiewicz A; Szkodzinski J; Polonski L; Zubelewicz-Szkodzinska B
    Eur Cytokine Netw; 2014; 25(3):41-5. PubMed ID: 25373851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response.
    Kunes P; Holubcova Z; Kolackova M; Krejsek J
    Mediators Inflamm; 2012; 2012():920517. PubMed ID: 22577258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Long Pentraxin PTX3 in Bone Homeostasis and Pathology.
    Parente R; Sobacchi C; Bottazzi B; Mantovani A; Grčevic D; Inforzato A
    Front Immunol; 2019; 10():2628. PubMed ID: 31787987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer.
    Doni A; Stravalaci M; Inforzato A; Magrini E; Mantovani A; Garlanda C; Bottazzi B
    Front Immunol; 2019; 10():712. PubMed ID: 31019517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.